{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:53:01Z","timestamp":1791571981280,"version":"4.3.4"},"reference-count":246,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.pbb.2011.03.022","type":"journal-article","created":{"date-parts":[[2011,4,9]],"date-time":"2011-04-09T06:29:56Z","timestamp":1302330596000},"page":"130-145","source":"Crossref","is-referenced-by-count":113,"title":["Drug targets for cognitive enhancement in neuropsychiatric disorders"],"prefix":"10.1016","volume":"99","author":[{"given":"Tanya L.","family":"Wallace","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa M.","family":"Ballard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Pouzet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim J.","family":"Riedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph G.","family":"Wettstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2011.03.022_bb0005","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1472-8206.2006.00411.x","article-title":"Antipsychotic-like profile of thioperamide, a selective H3-receptor antagonist in mice","volume":"20","author":"Akhtar","year":"2006","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb0010","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bbr.2008.12.010","article-title":"The role of histamine on cognition","volume":"199","author":"Alvarez","year":"2009","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2011.03.022_bb0015","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0022-3565(25)24797-8","article-title":"5-Hydroxytryptamine4-like receptors mediate the slow excitatory response to serotonin in the rat hippocampus","volume":"257","author":"Andrade","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.03.022_bb0020","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1113\/jphysiol.1987.sp016862","article-title":"Pharmacologically distinct actions of serotonin on single pyramidal neurones of the rat hippocampus recorded in vitro","volume":"394","author":"Andrade","year":"1987","journal-title":"J Physiol"},{"key":"10.1016\/j.pbb.2011.03.022_bb0025","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0165-0173(98)00050-2","article-title":"Metabotropic glutamate receptors: electrophysiological properties and role in plasticity","volume":"29","author":"Anwyl","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2011.03.022_bb0030","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF02245056","article-title":"Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys","volume":"116","author":"Arnsten","year":"1994","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2011.03.022_bb0035","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/302832a0","article-title":"Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor","volume":"302","author":"Arrang","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2011.03.022_bb0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pharmthera.2009.09.001","article-title":"Preclinical and clinical pharmacology of the GABAA receptor alpha5 subtype-selective inverse agonist alpha5IA","volume":"125","author":"Atack","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pbb.2011.03.022_bb0045","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neuropharm.2006.04.018","article-title":"L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for alpha5-containing GABAA receptors","volume":"51","author":"Atack","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2011.03.022_bb0050","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1124\/jpet.109.157636","article-title":"In vitro and in vivo properties of 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylme thoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA receptor alpha5 subtype-selective inverse agonist","volume":"331","author":"Atack","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.03.022_bb0055","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s002130000590","article-title":"Distinct contributions of glutamate and dopamine receptors to temporal aspects of rodent working memory using a clinically relevant task","volume":"153","author":"Aultman","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2011.03.022_bb0060","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/npp.2009.30","article-title":"mGluR5 positive allosteric modulators facilitate both hippocampal LTP and LTD and enhance spatial learning","volume":"34","author":"Ayala","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2011.03.022_bb0065","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0022-3565(24)39121-9","article-title":"5-Hydroxytryptamine(7) receptor activation decreases slow afterhyperpolarization amplitude in CA3 hippocampal pyramidal cells","volume":"294","author":"Bacon","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.03.022_bb0070","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00213-008-1357-7","article-title":"RO4938581, a novel cognitive enhancer acting at GABAA alpha5 subunit-containing receptors","volume":"202","author":"Ballard","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.pbb.2011.03.022_bb0075","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1517\/14728222.7.1.101","article-title":"CREB, memory enhancement and the treatment of memory disorders: promises, pitfalls and prospects","volume":"7","author":"Barco","year":"2003","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.pbb.2011.03.022_bb0080","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0028-3908(99)00010-6","article-title":"A review of central 5-HT receptors and their function","volume":"38","author":"Barnes","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2011.03.022_bb0110","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.neubiorev.2010.01.012","article-title":"Assessing cognitive function in clinical trials of schizophrenia","volume":"34","author":"Barnett","year":"2010","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pbb.2011.03.022_bb0085","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.tins.2004.04.009","article-title":"The mGluR theory of fragile X mental retardation","volume":"27","author":"Bear","year":"2004","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pbb.2011.03.022_bb0090","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/jmg.2008.063701","article-title":"A pilot open label, single dose trial of fenobam in adults with fragile X syndrome","volume":"46","author":"Berry-Kravis","year":"2009","journal-title":"J Med Genet"},{"key":"10.1016\/j.pbb.2011.03.022_bb0095","doi-asserted-by":"crossref","first-page":"6971","DOI":"10.1073\/pnas.90.15.6971","article-title":"Mutations at two distinct sites within the channel domain M2 alter calcium permeability of neuronal alpha 7 nicotinic receptor","volume":"90","author":"Bertrand","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pbb.2011.03.022_bb0100","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0022-3565(25)09528-X","article-title":"Identification of the primary muscarinic autoreceptor subtype in rat striatum as m2 through a correlation of in vivo microdialysis and in vitro receptor binding data","volume":"273","author":"Billard","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.03.022_bb0105","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s00213-004-2065-6","article-title":"Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data","volume":"179","author":"Black","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2011.03.022_bb0115","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1113\/jphysiol.1973.sp010274","article-title":"Long-lasting potentiation of synaptic transmission in the dentate area of the unanaestetized rabbit following stimulation of the perforant path","volume":"232","author":"Bliss","year":"1973","journal-title":"J Physiol"},{"key":"10.1016\/j.pbb.2011.03.022_bb0120","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.2174\/138161206777698855","article-title":"Improving memory: a role for phosphodiesterases","volume":"12","author":"Blokland","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pbb.2011.03.022_bb0125","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.neubiorev.2009.08.001","article-title":"Participation of D 1\u20134 dopamine receptors in the pro-cognitive effects of angiotensin IV and des-Phe 6 angiotensin IV","volume":"34","author":"Braszko","year":"2010","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pbb.2011.03.022_bb0130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bbr.2003.11.001","article-title":"Enhancement of prepulse inhibition of startle in mice by the H3 receptor antagonists thioperamide and ciproxifan","volume":"153","author":"Browman","year":"2004","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2011.03.022_bb1195","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.biopsych.2010.09.052","article-title":"A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia","volume":"69","author":"Buchanan","year":"2011","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2011.03.022_bb0135","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3109\/07853890008998828","article-title":"Role of serotonin in memory impairment","volume":"32","author":"Buhot","year":"2000","journal-title":"Ann Med"},{"key":"10.1016\/j.pbb.2011.03.022_bb0140","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0006-8993(95)00104-X","article-title":"The distribution of 5-HT1A and 5-HT2A receptor mRNA in human brain","volume":"676","author":"Burnet","year":"1995","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2011.03.022_bb0145","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1046\/j.1460-9568.2003.02588.x","article-title":"Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis, and pilocarpine-induced seizure activity","volume":"17","author":"Bymaster","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pbb.2011.03.022_bb0150","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/9780470751251.ch17","article-title":"What can we learn from the disrupted in schizophrenia 1 interactome: lessons for target identification and disease biology?","volume":"289","author":"Camargo","year":"2008","journal-title":"Novartis Found Symp"},{"key":"10.1016\/j.pbb.2011.03.022_bb0155","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/j.1460-9568.2007.05431.x","article-title":"Maintenance of superior learning and memory function in NR2B transgenic mice during ageing","volume":"25","author":"Cao","year":"2007","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pbb.2011.03.022_bb0160","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1471-4159.2000.0750889.x","article-title":"Regulation of neurotransmitter release by metabotropic glutamate receptors","volume":"75","author":"Cartmell","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.pbb.2011.03.022_bb0165","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1126\/science.167.3926.1745","article-title":"Neuronal mechanisms of habituation and dishabituation of the gill-withdrawal reflex in Aplysia","volume":"167","author":"Castellucci","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.pbb.2011.03.022_bb1200","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.biopsych.2010.01.001","article-title":"Reversal of ketamine-induced working memory impairments by the GABA-A alpha2\/3 agonist TPA023","volume":"67","author":"Castner","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2011.03.022_bb0170","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0304-3940(93)90876-M","article-title":"Brief-lifetime, fast-inactivating ion channels account for the alpha-bungarotoxin-sensitive nicotinic response in hippocampal neurons","volume":"164","author":"Castro","year":"1993","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pbb.2011.03.022_bb0175","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0006-3495(95)80213-4","article-title":"alpha-Bungarotoxin-sensitive hippocampal nicotinic receptor channel has a high calcium permeability","volume":"68","author":"Castro","year":"1995","journal-title":"Biophys J"},{"key":"10.1016\/j.pbb.2011.03.022_bb0180","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1212\/01.wnl.0000260240.46070.7c","article-title":"AMPA potentiator treatment of cognitive deficits in Alzheimer disease","volume":"68","author":"Chappell","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.pbb.2011.03.022_bb0185","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.neuropharm.2009.07.027","article-title":"GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders","volume":"57","author":"Charych","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2011.03.022_bb0190","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0197-4580(00)00196-2","article-title":"Deficits in the expression of the NR2B subunit in the hippocampus of aged Fisher 344 rats","volume":"22","author":"Clayton","year":"2001","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pbb.2011.03.022_bb0195","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1523\/JNEUROSCI.22-09-03628.2002","article-title":"A hippocampal NR2B deficit can mimic age-related changes in long-term potentiation and spatial learning in the Fischer 344 rat","volume":"22","author":"Clayton","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pbb.2011.03.022_bb0200","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00213-006-0361-z","article-title":"An inverse agonist selective for alpha5 subunit-containing GABAA receptors improves encoding and recall but not consolidation in the Morris water maze","volume":"188","author":"Collinson","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2011.03.022_bb0205","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.tips.2008.12.002","article-title":"Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders","volume":"30","author":"Conn","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pbb.2011.03.022_bb0210","doi-asserted-by":"crossref","first-page":"8980","DOI":"10.1073\/pnas.142288699","article-title":"Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors","volume":"99","author":"Crestani","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pbb.2011.03.022_bb0215","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/cercor\/bhh147","article-title":"Localization of the GLYT1 glycine transporter at glutamatergic synapses in the rat brain","volume":"15","author":"Cubelos","year":"2005","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.pbb.2011.03.022_bb0220","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cell.2008.09.060","article-title":"Neurofibromin regulation of ERK signaling modulates GABA release and learning","volume":"135","author":"Cui","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.pbb.2011.03.022_bb0225","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s002130050482","article-title":"Differentiating the effects of centrally acting drugs on arousal and memory: an event-related potential study of scopolamine, lorazepam and diphenhydramine","volume":"135","author":"Curran","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2011.03.022_bb0230","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1124\/jpet.105.092320","article-title":"An inverse agonist selective for alpha5 subunit-containing GABAA receptors enhances cognition","volume":"316","author":"Dawson","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.03.022_bb0235","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1073\/pnas.0510212103","article-title":"Identification of a genetic cluster influencing memory performance and hippocampal activity in humans","volume":"103","author":"De Quervain","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pbb.2011.03.022_bb0240","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00002826-200101000-00008","article-title":"A revised excitotoxic hypothesis of schizophrenia: therapeutic implications","volume":"24","author":"Deutsch","year":"2001","journal-title":"Clin Neuropharmacol"},{"issue":"4","key":"10.1016\/j.pbb.2011.03.022_bb0245","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00213-005-0232-z","article-title":"Phosphodiesterase inhibition by sildenafil citrate attenuates a maze learning impairment in rats induced by nitric oxide synthase inhibition","volume":"183","author":"Devan","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2011.03.022_bb0250","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0028-3908(01)00193-9","article-title":"Presynaptic group II metabotropic glutamate receptors reduce stimulated and spontaneous transmitter release in human dentate gyrus","volume":"42","author":"Dietrich","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2011.03.022_bb0255","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1113\/jphysiol.2008.150722","article-title":"Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome","volume":"586","author":"Dolen","year":"2008","journal-title":"J Physiol"},{"key":"10.1016\/j.pbb.2011.03.022_bb0260","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.neuron.2007.12.001","article-title":"Correction of fragile X syndrome in mice","volume":"56","author":"Dolen","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.pbb.2011.03.022_bb0265","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(83)90076-4","article-title":"Severe anxiety induced by FG 7142, a beta-carboline ligand for benzodiazepine receptors","volume":"2","author":"Dorow","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.pbb.2011.03.022_bb0270","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF02246647","article-title":"The effects of a benzodiazepine receptor antagonist beta-carboline ZK-93426 on scopolamine-induced impairment on attention, memory and psychomotor skills","volume":"123","author":"Duka","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2011.03.022_bb0275","doi-asserted-by":"crossref","first-page":"12604","DOI":"10.1073\/pnas.0405077101","article-title":"Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia","volume":"101","author":"Egan","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 1","key":"10.1016\/j.pbb.2011.03.022_bb0280","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1007\/s00011-005-0035-z","article-title":"Differences in pharmacological properties of histamine H(3) receptor agonists and antagonists revealed at two human H(3) receptor isoforms","volume":"55","author":"Esbenshade","year":"2006","journal-title":"Inflamm Res"},{"key":"10.1016\/j.pbb.2011.03.022_bb0285","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/bjp.2008.147","article-title":"The histamine H3 receptor: an attractive target for the treatment of cognitive disorders","volume":"154","author":"Esbenshade","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb0290","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1124\/jpet.104.076547","volume":"312","author":"Feinberg","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.03.022_bb0295","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nn1860","article-title":"Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome","volume":"10","author":"Fernandez","year":"2007","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pbb.2011.03.022_bb0300","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.pnpbp.2009.11.018","article-title":"Elevated level of metabotropic glutamate receptor 2\/3 in the prefrontal cortex in major depression","volume":"34","author":"Feyissa","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pbb.2011.03.022_bb0305","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1523\/JNEUROSCI.13-05-02001.1993","article-title":"Differential localization of phosphoinositide-linked metabotropic glutamate receptor (mGluR1) and the inositol 1,4,5-trisphosphate receptor in rat brain","volume":"13","author":"Fotuhi","year":"1993","journal-title":"J Neurosci"},{"issue":"Suppl 1","key":"10.1016\/j.pbb.2011.03.022_bb0310","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1007\/s00011-004-0410-1","article-title":"Selective H3 receptor (H3R) blockade: broad efficacy in cognition and schizophrenia","volume":"54","author":"Fox","year":"2005","journal-title":"Inflamm Res"},{"issue":"1","key":"10.1016\/j.pbb.2011.03.022_bb0315","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0092-8674(94)90394-8","article-title":"CREB: a mediator of long-term memory from mollusks to mammals","volume":"79","author":"Frank","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.pbb.2011.03.022_bb0320","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1176\/appi.ajp.2008.07071135","article-title":"Initial phase 2 trial of a nicotinic agonist in schizophrenia","volume":"165","author":"Freedman","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2011.03.022_bb0325","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0304-3940(92)90345-8","article-title":"Measuring the neuromodulatory effects of drugs in man with positron emission tomography","volume":"141","author":"Friston","year":"1992","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pbb.2011.03.022_bb0330","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/cne.903590111","article-title":"GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits","volume":"359","author":"Fritschy","year":"1995","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pbb.2011.03.022_bb1205","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1176\/ajp.152.8.1213","article-title":"A dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia","volume":"152","author":"Goff","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2011.03.022_bb1210","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.schres.2008.08.012","article-title":"Once-weekly D-cycloserine effects on negative symptoms and cognition in schizophrenia: an exploratory study","volume":"106","author":"Goff","year":"2008","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pbb.2011.03.022_bb0335","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/sj.npp.1301444","article-title":"A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia","volume":"33","author":"Goff","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2011.03.022_bb0340","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00213-008-1278-5","article-title":"A placebo-controlled study of sildenafil effects on cognition in schizophrenia","volume":"202","author":"Goff","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2011.03.022_bb0345","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00213-004-1793-y","article-title":"Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction","volume":"174","author":"Goldman-Rakic","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2011.03.022_bb0350","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1523\/JNEUROSCI.16-14-04491.1996","article-title":"Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease","volume":"16","author":"Gomez-Isla","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.pbb.2011.03.022_bb0355","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.tips.2006.07.004","article-title":"Brain nicotinic acetylcholine receptors: native subtypes and their relevance","volume":"27","author":"Gotti","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pbb.2011.03.022_bb0360","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1460-9568.1992.tb00145.x","article-title":"The effect of apomorphine and buspirone on regional cerebral blood flow during the performance of a cognitive task-measuring neuromodulatory effects of psychotropic drugs in man","volume":"4","author":"Grasby","year":"1992","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pbb.2011.03.022_bb0365","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1023\/A:1017573722074","article-title":"Sildenafil (Viagra): is there an influence on psychological performance?","volume":"32","author":"Grass","year":"2001","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.pbb.2011.03.022_bb0370","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1124\/jpet.109.155994","article-title":"Phosphodiesterase 10A inhibitor activity in preclinical models of the positive, cognitive, and negative symptoms of schizophrenia","volume":"331","author":"Grauer","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.03.022_bb0375","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/156802610790411018","article-title":"Metabotropic glutamate receptors as therapeutic targets for cognitive disorders","volume":"10","author":"Gravius","year":"2010","journal-title":"Curr Top Med Chem"},{"issue":"1","key":"10.1016\/j.pbb.2011.03.022_bb1215","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.schres.2004.09.009","article-title":"Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS","volume":"72","author":"Green","year":"2004","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pbb.2011.03.022_bb0380","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00213-005-2212-8","article-title":"GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon","volume":"180","author":"Guidotti","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2011.03.022_bb0385","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0014-2999(03)02182-4","article-title":"The effect of (+\/\u2212)-CP-101,606, an NMDA receptor NR2B subunit selective antagonist, in the Morris watermaze","volume":"476","author":"Guscott","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb0390","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1152\/physrev.00043.2007","article-title":"Histamine in the nervous system","volume":"88","author":"Haas","year":"2008","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pbb.2011.03.022_bb0395","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1124\/jpet.108.138586","article-title":"Antipsychotic-like properties of phosphodiesterase 4 inhibitors: evaluation of 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (RO-20-1724) with auditory event-related potentials and prepulse inhibition of startle","volume":"326","author":"Halene","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.03.022_bb0400","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00213-007-0742-y","article-title":"Stimulation of the metabotropic glutamate 2\/3 receptor attenuates social novelty discrimination deficits induced by neonatal phencyclidine treatment","volume":"192","author":"Harich","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2011.03.022_bb0405","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/0269881108089818","article-title":"The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): expression, function and involvement in schizophrenia","volume":"22","author":"Harrison","year":"2008","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb0410","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/157015906778520764","article-title":"The pharmacology of the neurochemical transmission in the midbrain raphe nuclei of the rat","volume":"4","author":"Harsing","year":"2006","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb0415","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1176\/ajp.148.1.73","article-title":"Effects of buspirone and alprazolam on the cognitive performance of normal elderly subjects","volume":"148","author":"Hart","year":"1991","journal-title":"Am J Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.pbb.2011.03.022_bb0420","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.schres.2011.01.004","article-title":"Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone","volume":"127","author":"Harvey","year":"2011","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pbb.2011.03.022_bb0425","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nn.2487","article-title":"Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1","volume":"13","author":"Hayashi-Takagi","year":"2010","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pbb.2011.03.022_bb0430","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.euroneuro.2007.08.002","article-title":"Phosphodiesterase 10A inhibition is associated with locomotor and cognitive deficits and increased anxiety in mice","volume":"18","author":"Hebb","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb0435","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0028-3908(02)00402-1","article-title":"Evaluation of the NR2B-selective NMDA receptor antagonist Ro 63-1908 on rodent behaviour: evidence for an involvement of NR2B NMDA receptors in response inhibition","volume":"44","author":"Higgins","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2011.03.022_bb0440","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.neuropharm.2004.01.018","article-title":"Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodent","volume":"46","author":"Higgins","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2011.03.022_bb0445","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00213-005-2203-9","article-title":"Evidence for improved performance in cognitive tasks following selective NR2B NMDA receptor antagonist pre-treatment in the rat","volume":"179","author":"Higgins","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2011.03.022_bb0450","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/BF00191912","article-title":"Single dose human pharmacology of umespirone","volume":"46","author":"Holland","year":"1994","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb0455","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/npp.2010.9","article-title":"Enhancement of attentional performance by selective stimulation of alpha4beta2(*) nAChRs: underlying cholinergic mechanisms","volume":"35","author":"Howe","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2011.03.022_bb0460","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0306-4522(00)00163-9","article-title":"Density and pharmacology of alpha5 subunit-containing GABA(A) receptors are preserved in hippocampus of Alzheimer's disease patients","volume":"98","author":"Howell","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2011.03.022_bb0465","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0166-4328(96)00109-X","article-title":"Classification and nomenclature of 5-HT receptors: a comment on current issues","volume":"73","author":"Hoyer","year":"1996","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2011.03.022_bb0470","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/j.1471-4159.2008.05554.x","article-title":"Negative regulation of neurogenesis and spatial memory by NR2B-containing NMDA receptors","volume":"106","author":"Hu","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.pbb.2011.03.022_bb0475","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11920-999-0007-z","article-title":"Treatment of negative and cognitive symptoms","volume":"1","author":"Javitt","year":"1999","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.pbb.2011.03.022_bb0480","first-page":"468","article-title":"Glycine transport inhibitors for the treatment of schizophrenia: symptom and disease modification","volume":"12","author":"Javitt","year":"2009","journal-title":"Curr Opin Drug Discov Devel"},{"key":"10.1016\/j.pbb.2011.03.022_bb0485","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2011.03.022_bb0490","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0361-9230(87)90104-3","article-title":"Bidirectional effects of beta-carbolines and benzodiazepines on cognitive processes","volume":"19","author":"Jensen","year":"1987","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pbb.2011.03.022_bb0495","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1037\/0033-2909.101.1.28","article-title":"Effects of mood and severity on memory processes in depression and mania","volume":"101","author":"Johnson","year":"1987","journal-title":"Psychol Bull"},{"key":"10.1016\/j.pbb.2011.03.022_bb0500","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2005.09.058","article-title":"A metabotropic glutamate 2\/3 receptor antagonist, MGS0039, increases extracellular dopamine levels in the nucleus accumbens shell","volume":"393","author":"Karasawa","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pbb.2011.03.022_bb0505","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbr.2007.07.033","article-title":"d-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats","volume":"186","author":"Karasawa","year":"2008","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2011.03.022_bb0510","first-page":"62","article-title":"From science to application: the development of an intervention package","volume":"12","author":"Kegeles","year":"2000","journal-title":"AIDS Educ Prev"},{"key":"10.1016\/j.pbb.2011.03.022_bb0515","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00213-005-2200-z","article-title":"Ionotropic and metabotropic glutamate receptor structure and pharmacology","volume":"179","author":"Kew","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2011.03.022_bb0520","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0028-3908(00)00118-0","article-title":"Activity-dependent presynaptic autoinhibition by group II metabotropic glutamate receptors at the perforant path inputs to the dentate gyrus and CA1","volume":"40","author":"Kew","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2011.03.022_bb0525","doi-asserted-by":"crossref","first-page":"13541","DOI":"10.1074\/jbc.M008035200","article-title":"alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity","volume":"276","author":"Kihara","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pbb.2011.03.022_bb0530","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/sj.mp.4002031","article-title":"Association of DISC1 with autism and Asperger syndrome","volume":"13","author":"Kilpinen","year":"2008","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pbb.2011.03.022_bb0535","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.tips.2008.07.001","article-title":"A role for the 5-HT(1A), 5-HT4 and 5-HT6 receptors in learning and memory","volume":"29","author":"King","year":"2008","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pbb.2011.03.022_bb0540","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/sj.npp.1300028","article-title":"Safety, pharmacokinetics, and effects on cognitive function of multiple doses of GTS-21 in healthy, male volunteers","volume":"28","author":"Kitagawa","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2011.03.022_bb0545","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bbr.2004.11.008","article-title":"Effects of histamine H3 receptor antagonists in two models of spatial learning","volume":"159","author":"Komater","year":"2005","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2011.03.022_bb0550","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00213-004-1982-8","article-title":"Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects","volume":"179","author":"Krystal","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2011.03.022_bb0555","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1126\/science.167.3926.1743","article-title":"Neuronal correlates of habituation and dishabituation of the gill-withdrawal reflex in Aplysia","volume":"167","author":"Kupfermann","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.pbb.2011.03.022_bb0560","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1001\/archpsyc.62.11.1196","article-title":"Sarcosine or d-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study","volume":"62","author":"Lane","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pbb.2011.03.022_bb0565","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.biopsych.2006.04.005","article-title":"Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia","volume":"60","author":"Lane","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2011.03.022_bb0570","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1017\/S1461145709990939","article-title":"A randomized, double-blind, placebo-controlled comparison study of sarcosine (N-methylglycine) and d-serine add-on treatment for schizophrenia","volume":"13","author":"Lane","year":"2010","journal-title":"Int J Neuropsychopharmacol\/official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)"},{"issue":"1","key":"10.1016\/j.pbb.2011.03.022_bb0575","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1124\/mol.105.017814","article-title":"Probing the molecular mechanism of interaction between 4-n-butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the muscarinic M(1) receptor: direct pharmacological evidence that AC-42 is an allosteric agonist","volume":"69","author":"Langmead","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb0580","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.pharmthera.2007.09.009","article-title":"Muscarinic acetylcholine receptors as CNS drug targets","volume":"117","author":"Langmead","year":"2008","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pbb.2011.03.022_bb0585","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.biopsych.2006.12.003","article-title":"Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-Methyl-d-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex","volume":"62","author":"Lecourtier","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2011.03.022_bb0590","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejphar.2009.12.043","article-title":"Metabotropic glutamate mGlu1 receptor stimulation and blockade: therapeutic opportunities in psychiatric illness","volume":"639","author":"Lesage","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb0595","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0165-6147(98)01201-2","article-title":"Therapeutic potential of histamine H3 receptor agonists and antagonists","volume":"19","author":"Leurs","year":"1998","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pbb.2011.03.022_bb0600","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1523\/JNEUROSCI.11-10-03218.1991","article-title":"Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies","volume":"11","author":"Levey","year":"1991","journal-title":"J Neurosci"},{"issue":"8","key":"10.1016\/j.pbb.2011.03.022_bb0605","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.bcp.2007.07.019","article-title":"Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function","volume":"74","author":"Levin","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb0610","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1176\/appi.ajp.2008.08030395","article-title":"Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia","volume":"165","author":"Lewis","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2011.03.022_bb0615","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neulet.2006.02.053","article-title":"Association of attention-deficit\/hyperactivity disorder with serotonin 4 receptor gene polymorphisms in Han Chinese subjects","volume":"401","author":"Li","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pbb.2011.03.022_bb0620","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.neuropharm.2006.03.014","article-title":"Effects of mGlu2 or mGlu3 receptor deletions on mGlu2\/3 receptor agonist (LY354740)-induced brain c-Fos expression: specific roles for mGlu2 in the amygdala and subcortical nuclei, and mGlu3 in the hippocampus","volume":"51","author":"Linden","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2011.03.022_bb0625","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1124\/jpet.108.136580","article-title":"ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piper idin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activities","volume":"327","author":"Liu","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.03.022_bb0630","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.euroneuro.2008.07.012","article-title":"Blockade of dopamine D(3) receptors in frontal cortex, but not in sub-cortical structures, enhances social recognition in rats: similar actions of D(1) receptor agonists, but not of D(2) antagonists","volume":"19","author":"Loiseau","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb0635","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1126\/science.290.5489.131","article-title":"Molecular and neuronal substrate for the selective attenuation of anxiety","volume":"290","author":"Low","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.pbb.2011.03.022_bb0640","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.coph.2003.09.009","article-title":"AMPA receptor modulators as cognitive enhancers","volume":"4","author":"Lynch","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb0645","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2174\/156720510791383831","article-title":"Double-blind, controlled phase II study of a 5-HT6 receptor antagonist, SB-742457, in Alzheimer's disease","volume":"7","author":"Maher-Edwards","year":"2010","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.pbb.2011.03.022_bb0650","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/37605","article-title":"Fear conditioning induces a lasting potentiation of synaptic currents in vitro","volume":"390","author":"McKernan","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2011.03.022_bb0655","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/75761","article-title":"Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype","volume":"3","author":"McKernan","year":"2000","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pbb.2011.03.022_bb0660","series-title":"Benzodiazepine receptor antagonists flumazenil and CGS 8216 and inverse-agonist b-CCM enhance spatial learning in the rat: dissociation from anxiogenic actions","author":"McNamara","year":"1993"},{"key":"10.1016\/j.pbb.2011.03.022_bb0665","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.bcp.2007.01.007","article-title":"Structurally novel histamine H3 receptor antagonists GSK207040 and GSK334429 improve scopolamine-induced memory impairment and capsaicin-induced secondary allodynia in rats","volume":"73","author":"Medhurst","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb0670","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/sj.npp.1300869","article-title":"Effects of 5-HT on memory and the hippocampus: model and data","volume":"31","author":"Meeter","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2011.03.022_bb0675","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0091-3057(95)00248-U","article-title":"Effects of thioperamide, a histamine H3 antagonist, on the step-through passive avoidance response and histidine decarboxylase activity in senescence-accelerated mice","volume":"50","author":"Meguro","year":"1995","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2011.03.022_bb0680","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1471-4892(01)00116-3","article-title":"Serotonergic targets in depression","volume":"2","author":"Middlemiss","year":"2002","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb0685","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/mol.106.025130","article-title":"Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors","volume":"70","author":"Mihalak","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb0690","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1124\/jpet.107.134536","volume":"324","author":"Millan","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.03.022_bb0695","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1126\/science.281.5381.1349","article-title":"Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats","volume":"281","author":"Moghaddam","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.pbb.2011.03.022_bb0700","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00441-006-0284-3","article-title":"GABA(A) receptor diversity and pharmacology","volume":"326","author":"Mohler","year":"2006","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.pbb.2011.03.022_bb0705","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/0024-3205(93)90592-Q","article-title":"Involvement of histamine in the control of the waking state","volume":"53","author":"Monti","year":"1993","journal-title":"Life Sci"},{"key":"10.1016\/j.pbb.2011.03.022_bb0710","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.drugalcdep.2009.04.005","article-title":"Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia","volume":"104","author":"Moss","year":"2009","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pbb.2011.03.022_bb0715","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1046\/j.1471-4159.1998.71062558.x","article-title":"Characterization of (2S,2\u2032R,3\u2032R)-2-(2\u2032,3\u2032-[3H]-dicarboxycyclopropyl)glycine binding in rat brain","volume":"71","author":"Mutel","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.pbb.2011.03.022_bb0720","doi-asserted-by":"crossref","first-page":"829","DOI":"10.4088\/JCP.08m04905","article-title":"Lurasidone in the treatment of acute schizophrenia: a double-blind, placebo-controlled trial","volume":"70","author":"Nakamura","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pbb.2011.03.022_bb0725","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/1099-1077(200008)15:6<397::AID-HUP212>3.0.CO;2-L","article-title":"A review of the role of serotonin receptors in psychiatric disorders","volume":"15","author":"Naughton","year":"2000","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb0730","doi-asserted-by":"crossref","first-page":"19012","DOI":"10.1074\/jbc.M110.125096","article-title":"Structural determinants of allosteric agonism and modulation at the M4 muscarinic acetylcholine receptor: identification of ligand-specific and global activation mechanisms","volume":"285","author":"Nawaratne","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pbb.2011.03.022_bb0735","series-title":"Molecular neuropharmacology: a foundation for clinical neuroscience","first-page":"457","article-title":"Memory and dementia","author":"Nestler","year":"2001"},{"key":"10.1016\/j.pbb.2011.03.022_bb0740","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0197-4580(88)80084-8","article-title":"Enhanced passive avoidance retention following posttrain serotonergic receptor antagonist administration in middle-aged and aged rats","volume":"9","author":"Normile","year":"1988","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pbb.2011.03.022_bb0745","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jpsychires.2008.01.013","article-title":"Positive association of the PDE4B (phosphodiesterase 4B) gene with schizophrenia in the Japanese population","volume":"43","author":"Numata","year":"2008","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pbb.2011.03.022_bb0750","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.neuropharm.2007.08.008","article-title":"Blockade of alcohol's amnestic activity in humans by an alpha5 subtype benzodiazepine receptor inverse agonist","volume":"53","author":"Nutt","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2011.03.022_bb0755","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/0306-4522(93)90485-X","article-title":"Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat","volume":"53","author":"Ohishi","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2011.03.022_bb0760","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0896-6273(94)90459-6","article-title":"Immunohistochemical localization of metabotropic glutamate receptors, mGluR2 and mGluR3, in rat cerebellar cortex","volume":"13","author":"Ohishi","year":"1994","journal-title":"Neuron"},{"key":"10.1016\/j.pbb.2011.03.022_bb0765","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1001\/archpsyc.63.6.630","article-title":"Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia","volume":"63","author":"Olincy","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pbb.2011.03.022_bb0770","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2174\/1568007043337508","article-title":"AMPA receptor potentiators for the treatment of CNS disorders","volume":"3","author":"O'Neill","year":"2004","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"10.1016\/j.pbb.2011.03.022_bb1220","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000172620","article-title":"Effects of D-cycloserine administration on weekly nonemotional memory tasks in healthy participants","volume":"78","author":"Otto","year":"2009","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.pbb.2011.03.022_bb0775","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1093\/hmg\/ddm207","article-title":"Association of distinct allelic haplotypes of DISC1 with psychotic and bipolar spectrum disorders and with underlying cognitive impairments","volume":"16","author":"Palo","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pbb.2011.03.022_bb0780","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/sj.npp.1300638","article-title":"Endogenous neurotensin in the ventral tegmental area contributes to amphetamine behavioral sensitization","volume":"30","author":"Panayi","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2011.03.022_bb0785","doi-asserted-by":"crossref","first-page":"P29-P","DOI":"10.1016\/j.clpt.2004.12.001","article-title":"Age\u2013gender study of SRA-333, a novel 5-HT1A antagonist","volume":"77","author":"Patat","year":"2005","journal-title":"Clin Pharmacol Ther"},{"issue":"Pt 3","key":"10.1016\/j.pbb.2011.03.022_bb0790","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1113\/jphysiol.1994.sp020469","article-title":"Transient and long-lasting actions of 5-HT on rat dentate gyrus neurones in vitro","volume":"481","author":"Piguet","year":"1994","journal-title":"J Physiol"},{"key":"10.1016\/j.pbb.2011.03.022_bb0795","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.bcp.2007.09.021","article-title":"Mood disorders: regulation by metabotropic glutamate receptors","volume":"75","author":"Pilc","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb0800","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bbr.2004.11.007","article-title":"The 5-HT1A receptor and recognition memory. Possible modulation of its behavioral effects by the nitrergic system","volume":"159","author":"Pitsikas","year":"2005","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2011.03.022_bb0805","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00213-008-1273-x","article-title":"Selective phosphodiesterase inhibitors: a promising target for cognition enhancement","volume":"202","author":"Reneerkens","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2011.03.022_bb0810","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.pnpbp.2008.11.018","article-title":"Effect of R3487\/MEM3454, a novel nicotinic alpha7 receptor partial agonist and 5-HT3 antagonist on sustained attention in rats","volume":"33","author":"Rezvani","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"5","key":"10.1016\/j.pbb.2011.03.022_bb1225","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1476-5381.1995.tb13303.x","article-title":"5-Hydroxytryptamine (5-HT)4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases","volume":"114","author":"Reynolds","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb0815","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s002130050845","article-title":"Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation","volume":"141","author":"Riedel","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2011.03.022_bb0820","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0893-133X(01)00361-X","article-title":"Dissociable hormonal, cognitive and mood responses to neuroendocrine challenge: evidence for receptor-specific serotonergic dysregulation in depressed mood","volume":"26","author":"Riedel","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2011.03.022_bb0825","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/WNR.0b013e3283381a4e","article-title":"Glycine transporter inhibition reverses ketamine-induced working memory deficits","volume":"21","author":"Roberts","year":"2010","journal-title":"Neuroreport"},{"key":"10.1016\/j.pbb.2011.03.022_bb0830","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1460-9568.2005.03937.x","article-title":"PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats","volume":"21","author":"Rodefer","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pbb.2011.03.022_bb0835","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/37601","article-title":"Fear conditioning induces associative long-term potentiation in the amygdala","volume":"390","author":"Rogan","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2011.03.022_bb0840","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.bcp.2009.05.033","article-title":"Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition","volume":"78","author":"Rollema","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb0845","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/cne.903550310","article-title":"Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain","volume":"355","author":"Romano","year":"1995","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pbb.2011.03.022_bb0850","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1124\/jpet.108.150094","article-title":"Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders","volume":"329","author":"Roncarati","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.03.022_bb0855","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejphar.2010.02.057","article-title":"Functional interaction of metabotropic glutamate receptor 5 and NMDA-receptor by a metabotropic glutamate receptor 5 positive allosteric modulator","volume":"639","author":"Rosenbrock","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb0860","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00213-003-1683-8","article-title":"Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders","volume":"174","author":"Roth","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2011.03.022_bb0865","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/44579","article-title":"Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes","volume":"401","author":"Rudolph","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2011.03.022_bb0870","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neulet.2007.12.039","article-title":"Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome","volume":"433","author":"Rueda","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pbb.2011.03.022_bb0875","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2174\/1568026023393877","article-title":"Memories are made of this (perhaps): a review of serotonin 5-HT(6) receptor ligands and their biological functions","volume":"2","author":"Russell","year":"2002","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.pbb.2011.03.022_bb0880","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1460-9568.2008.06349.x","article-title":"Enhanced long-term potentiation and impaired learning in phosphodiesterase 4D-knockout (PDE4D) mice","volume":"28","author":"Rutten","year":"2008","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pbb.2011.03.022_bb0885","first-page":"80","article-title":"Latrepirdine, a potential novel treatment for Alzheimer's disease and Huntington's chorea","volume":"11","author":"Sabbagh","year":"2010","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.pbb.2011.03.022_bb0890","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/nature04284","article-title":"Hypothalamic regulation of sleep and circadian rhythms","volume":"437","author":"Saper","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2011.03.022_bb0895","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.brainres.2008.02.020","article-title":"PWZ-029, a compound with moderate inverse agonist functional selectivity at GABA(A) receptors containing alpha5 subunits, improves passive, but not active, avoidance learning in rats","volume":"1208","author":"Savic","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2011.03.022_bb0900","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/385630a0","article-title":"Use-dependent increases in glutamate concentration activate presynaptic metabotropic glutamate receptors","volume":"385","author":"Scanziani","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2011.03.022_bb0905","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1124\/mol.53.2.228","article-title":"In vitro binding characteristics of a new selective group II metabotropic glutamate receptor radioligand, [3H]LY354740, in rat brain","volume":"53","author":"Schaffhauser","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb0910","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/gps.799","article-title":"A comparison of GMS-A\/AGECAT, DSM-III-R for dementia and depression, including subthreshold depression (SD)\u2014results from the Berlin Aging Study (BASE)","volume":"18","author":"Schaub","year":"2003","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.pbb.2011.03.022_bb0915","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1124\/jpet.105.086363","article-title":"Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties","volume":"314","author":"Schechter","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.pbb.2011.03.022_bb0920","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2174\/156802610790411009","article-title":"Phosphodiesterase inhibitors as potential cognition enhancing agents","volume":"10","author":"Schmidt","year":"2010","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.pbb.2011.03.022_bb0925","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/PL00007092","article-title":"Central effects of sildenafil (Viagra) on auditory selective attention and verbal recognition memory in humans: a study with event-related brain potentials","volume":"19","author":"Schultheiss","year":"2001","journal-title":"World J Urol"},{"key":"10.1016\/j.pbb.2011.03.022_bb0930","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1523\/JNEUROSCI.13-02-00596.1993","article-title":"Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium","volume":"13","author":"Seguela","year":"1993","journal-title":"J Neurosci"},{"key":"10.1016\/j.pbb.2011.03.022_bb0935","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0924-8196(00)80044-5","article-title":"Metabotropic glutamate receptors \u2014 immunocytochemical and in situ hybridization analyses","volume":"18","author":"Shigemoto","year":"2000","journal-title":"Handb Chem Neuroanat"},{"key":"10.1016\/j.pbb.2011.03.022_bb0940","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/cne.903220110","article-title":"Distribution of the mRNA for a metabotropic glutamate receptor (mGluR1) in the central nervous system: an in situ hybridization study in adult and developing rat","volume":"322","author":"Shigemoto","year":"1992","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pbb.2011.03.022_bb0945","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0304-3940(93)90227-C","article-title":"Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain","volume":"163","author":"Shigemoto","year":"1993","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pbb.2011.03.022_bb0950","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1744-859X-9-27","article-title":"A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia","volume":"9","author":"Shiina","year":"2010","journal-title":"Ann Gen Psychiatry"},{"key":"10.1016\/j.pbb.2011.03.022_bb0955","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejphar.2007.08.006","article-title":"Blockade of the metabotropic glutamate 2\/3 receptors enhances social memory via the AMPA receptor in rats","volume":"575","author":"Shimazaki","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb0960","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00213-010-1794-y","article-title":"d-Serine and a glycine transporter-1 inhibitor enhance social memory in rats","volume":"209","author":"Shimazaki","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2011.03.022_bb0965","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejphar.2009.12.039","article-title":"Metabotropic glutamate receptor subtype 5 antagonism in learning and memory","volume":"639","author":"Simonyi","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb0970","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2174\/1568007024606168","article-title":"Nicotinic agonists and psychosis","volume":"1","author":"Simosky","year":"2002","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"key":"10.1016\/j.pbb.2011.03.022_bb0975","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1111\/j.1751-553X.2009.01141.x","article-title":"Performance of automated slidemakers and stainers in a working laboratory environment \u2014 routine operation and quality control","volume":"32","author":"Simson","year":"2010","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.pbb.2011.03.022_bb0980","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.euroneuro.2009.02.004","article-title":"Interactions between the glycine transporter 1(GlyT1) inhibitor SSR504734 and psychoactive drugs in mouse motor behaviour","volume":"19","author":"Singer","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb0985","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s00213-004-2126-x","article-title":"Effects of the mGluR2\/3 agonist LY354740 on computerized tasks of attention and working memory in marmoset monkeys","volume":"179","author":"Spinelli","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2011.03.022_bb0990","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/01.fbp.0000081783.35927.8f","article-title":"Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders","volume":"14","author":"Spooren","year":"2003","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb0995","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2010.01.028","article-title":"Activation of type 5 metabotropic glutamate receptors attenuates deficits in cognitive flexibility induced by NMDA receptor blockade","volume":"639","author":"Stefani","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb1000","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ajmg.b.20060","article-title":"Association of a haplotype in the serotonin 5-HT4 receptor gene (HTR4) with Japanese schizophrenia","volume":"121B","author":"Suzuki","year":"2003","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.pbb.2011.03.022_bb1005","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/43432","article-title":"Genetic enhancement of learning and memory in mice","volume":"401","author":"Tang","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2011.03.022_bb1010","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00213-004-2114-1","article-title":"Selective serotonin 5-HT2A receptor antagonist EMD 281014 improves delayed matching performance in young and aged rhesus monkeys","volume":"179","author":"Terry","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2011.03.022_bb1015","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2174\/138161210790170094","article-title":"Cognitive improvement by activation of alpha7 nicotinic acetylcholine receptors: from animal models to human pathophysiology","volume":"16","author":"Thomsen","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pbb.2011.03.022_bb1020","article-title":"GABAa receptor inverse agonist fails to improve cognition in Alzheimer's disease patients","volume":"62","author":"Tolar","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.pbb.2011.03.022_bb1025","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.biopsych.2009.01.014","article-title":"Association between genes of Disrupted in schizophrenia 1 (DISC1) interactors and schizophrenia supports the role of the DISC1 pathway in the etiology of major mental illnesses","volume":"65","author":"Tomppo","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pbb.2011.03.022_bb1030","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/S0026-895X(25)09560-4","article-title":"5-Hydroxytryptamine4 receptors reduce afterhyperpolarization in hippocampus by inhibiting calcium-induced calcium release","volume":"50","author":"Torres","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb1035","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0006-3223(98)00279-0","article-title":"d-serine added to antipsychotics for the treatment of schizophrenia","volume":"44","author":"Tsai","year":"1998","journal-title":"Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.pbb.2011.03.022_bb1040","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrd1061","article-title":"Targeting the CREB pathway for memory enhancers","volume":"2","author":"Tully","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pbb.2011.03.022_bb1045","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1177\/0269881106059804","article-title":"Sedation and memory: studies with a histamine H-1 receptor antagonist","volume":"20","author":"Turner","year":"2006","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb1050","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/sj.npp.1300005","article-title":"Effects of the 5-HT2A agonist psilocybin on mismatch negativity generation and AX-continuous performance task: implications for the neuropharmacology of cognitive deficits in schizophrenia","volume":"28","author":"Umbricht","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2011.03.022_bb1055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0301-0511(96)05237-4","article-title":"Event-related potentials in a passive and active auditory condition: effects of diazepam and buspirone on slow wave positivity","volume":"46","author":"Unrug","year":"1997","journal-title":"Biol Psychol"},{"key":"10.1016\/j.pbb.2011.03.022_bb1060","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.nurt.2008.05.008","article-title":"5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease","volume":"5","author":"Upton","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pbb.2011.03.022_bb1065","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.neuropharm.2009.07.022","article-title":"Dose-dependent effect of CDPPB, the mGluR5 positive allosteric modulator, on recognition memory is associated with GluR1 and CREB phosphorylation in the prefrontal cortex and hippocampus","volume":"57","author":"Uslaner","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2011.03.022_bb1230","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.neuropharm.2008.07.005","article-title":"The novel selective PDE9 inhibitor BAY 73\u20136691 improves learning and memory in rodents","volume":"55","author":"van der Staay","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2011.03.022_bb1070","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejphar.2008.10.027","article-title":"Phosphodiesterase 2 and 5 inhibition attenuates the object memory deficit induced by acute tryptophan depletion","volume":"600","author":"van Donkelaar","year":"2008","journal-title":"Eur J Pharmacol"},{"issue":"Suppl 3","key":"10.1016\/j.pbb.2011.03.022_bb1075","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0924-977X(96)88173-9","article-title":"Flesinoxan improves cognition in the healthy elderly","volume":"6","author":"Van Harten","year":"1996","journal-title":"Eur Neuropsychopharmacol"},{"issue":"Suppl 3","key":"10.1016\/j.pbb.2011.03.022_bb1080","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0924-977X(96)87481-5","article-title":"No kinetic or dynamic interaction between flesinoxan and fluoxetine","volume":"6","author":"Van Harten","year":"1996","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb1085","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1177\/0269881107081526","article-title":"Histamine H1-receptor blockade in humans affects psychomotor performance but not memory","volume":"22","author":"Van Ruitenbeek","year":"2008","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb1090","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1476-5381.2009.00203.x","article-title":"Effects of l-histidine depletion and l-tyrosine\/l-phenylalanine depletion on sensory and motor processes in healthy volunteers","volume":"157","author":"Van Ruitenbeek","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb1095","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1476-5381.2008.00103.x","article-title":"Histamine H1 receptor blockade predominantly impairs sensory processes in human sensorimotor performance","volume":"157","author":"Van Ruitenbeek","year":"2009","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.pbb.2011.03.022_bb1100","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.brainresrev.2010.04.008","article-title":"Cognitive domains affected by histamine H(1)-antagonism in humans: a literature review","volume":"64","author":"Van Ruitenbeek","year":"2010","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.pbb.2011.03.022_bb1105","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1476-5381.2010.00907.x","article-title":"Histamine H1 receptor antagonist cetirizine impairs working memory processing speed, but not episodic memory","volume":"161","author":"Van Ruitenbeek","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb1110","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.euroneuro.2009.12.003","article-title":"Memory in humans is unaffected by central H1-antagonism, while objectively and subjectively measured sedation is increased","volume":"20","author":"Van Ruitenbeek","year":"2010","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb1115","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/321864a0","article-title":"Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks","volume":"321","author":"Venault","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2011.03.022_bb1120","first-page":"667","article-title":"Histamine-selective H3 receptor ligands and cognitive functions: an overview","volume":"7","author":"Vohora","year":"2004","journal-title":"IDrugs"},{"issue":"1","key":"10.1016\/j.pbb.2011.03.022_bb1125","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1124\/jpet.110.171892","article-title":"RG3487, a novel nicotinic alpha7 receptor partial agonist, improves cognition and sensorimotor gating in rodents","volume":"336","author":"Wallace","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2011.03.022_bb1130","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00213-005-0295-x","article-title":"The beta2 but not alpha7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice","volume":"184","author":"Walters","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2011.03.022_bb1135","doi-asserted-by":"crossref","first-page":"e7486","DOI":"10.1371\/journal.pone.0007486","article-title":"Genetic enhancement of memory and long-term potentiation but not CA1 long-term depression in NR2B transgenic rats","volume":"4","author":"Wang","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.pbb.2011.03.022_bb1140","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1476-5381.2010.00726.x","article-title":"Challenges for and current status of research into positive modulators of AMPA receptors","volume":"160","author":"Ward","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb1145","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/01.jcp.0000095349.32154.a5","article-title":"GABA and schizophrenia: a review of basic science and clinical studies","volume":"23","author":"Wassef","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pbb.2011.03.022_bb1150","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrd2379","article-title":"Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development","volume":"6","author":"Wess","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pbb.2011.03.022_bb1155","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1517\/13543784.16.7.967","article-title":"Histamine H3 receptor ligands break ground in a remarkable plethora of therapeutic areas","volume":"16","author":"Wijtmans","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.pbb.2011.03.022_bb1160","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1523\/JNEUROSCI.22-07-02843.2002","article-title":"The physiological role of 5-HT2A receptors in working memory","volume":"22","author":"Williams","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pbb.2011.03.022_bb1165","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1006\/nlme.2002.4077","article-title":"Site-selective N-methyl-d-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate antagonists produce distinct effects in rats performing complex discriminations","volume":"78","author":"Willmore","year":"2002","journal-title":"Neurobiol Learn Mem"},{"key":"10.1016\/j.pbb.2011.03.022_bb1170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2004.05.001","article-title":"Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system","volume":"103","author":"Witkin","year":"2004","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pbb.2011.03.022_bb1175","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2174\/187152707780363302","article-title":"Metabotropic glutamate receptors in the control of mood disorders","volume":"6","author":"Witkin","year":"2007","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.pbb.2011.03.022_bb1180","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1750-1326-3-15","article-title":"Evaluation of Dimebon in cellular model of Huntington's disease","volume":"3","author":"Wu","year":"2008","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.pbb.2011.03.022_bb1185","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1126\/science.273.5275.645","article-title":"Impairment of hippocampal mossy fiber LTD in mice lacking mGluR2","volume":"273","author":"Yokoi","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.pbb.2011.03.022_bb1190","first-page":"166","article-title":"Phosphodiesterase targets for cognitive dysfunction and schizophrenia\u2014a New York Academy of Sciences meeting","volume":"13","author":"Zhang","year":"2010","journal-title":"IDrugs"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305711001018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305711001018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T19:17:55Z","timestamp":1741115875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305711001018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":246,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0091305711001018"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2011.03.022","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}